MADRIGAL PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e4521d3a-8948-4e87-8d75-e20422a04f78/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-300.1M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-009514 |
| FY 2024 | $-497.9M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-007980 |
| FY 2023 | $-380.5M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-007376 |
| FY 2022 | $-293.6M | 2022-01-01 – 2022-12-31 | evidence 0001193125-23-045575 |
| FY 2021 | $-242.5M | 2021-01-01 – 2021-12-31 | evidence 0001193125-22-051569 |
| FY 2020 | $-206.7M | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-056164 |
| FY 2019 | $-95.0M | 2019-01-01 – 2019-12-31 | evidence 0001193125-20-049021 |
| FY 2018 | $-40.7M | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-000725 |
| FY 2017 | $-32.1M | 2017-01-01 – 2017-12-31 | evidence 0001047469-18-001557 |
| FY 2016 | $-25.2M | 2016-01-01 – 2016-12-31 | evidence 0001047469-18-001557 |
| FY 2015 | $-3.2M | 2015-01-01 – 2015-12-31 | evidence 0001047469-17-002260 |
| FY 2014 | $-84.0M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-002022 |
| FY 2013 | $-87.6M | 2013-01-01 – 2013-12-31 | evidence 0001047469-14-002088 |
| FY 2012 | $-60.9M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-002698 |
| FY 2011 | $-45.4M | 2011-01-01 – 2011-12-31 | evidence 0001047469-12-001243 |
| FY 2010 | $-36.9M | 2010-01-01 – 2010-12-31 | evidence 0001047469-12-001243 |
| FY 2009 | $79.3M | 2009-01-01 – 2009-12-31 | evidence 0001047469-12-001243 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MADRIGAL PHARMACEUTICALS, INC. — all facts · Revenue · Net Income